From complexity to clarity. Insight to impact.
Mirador360™ enables a quantum leap in precision medicine by harnessing cutting-edge biology, multi-modal data and advanced analytics to develop precision therapies. Scroll to see how it comes together.
Multi-modal data
M360 houses one of the most extensive repositories of immune-mediated disease data and is continually expanding. Our comprehensive database of curated, harmonized, high-quality public and private data, with integrated multiomics and clinical data, is the foundation of our engine.
Advanced analytics and AI-driven discovery
Advanced analytics, proprietary AI/ML models and supercharged deep-learning algorithms unlock hidden value from our database to deliver novel insights that inform smarter drug design.
Precision insights
The current landscape of immune-mediated disease therapies faces a critical challenge: limited target differentiation. M360 is built to break the efficacy ceiling and identify innovative therapeutic targets with greater degree of confidence. M360 insights enable smarter drug design, targeted drug combinations and multispecifics, indication selection and diagnostic development to identify patients most likely to benefit.
Pipeline of first & best-in-class therapies
The result: first- and best-in-class therapies with higher probability of success and accelerated paths to clinic and market.